ASH Distinguished Scientist Award
The purpose of the ASH Distinguished Scientist Award is to honor a scientist
or physician for outstanding achievements in the field of hypertension.
One ASH Distinguished Scientist Award is given each year depending on
the field to which the award recipient has made his or her contribution.
The award recipient receives a framed certificate and an honorarium. The
awardee is also requested to present a 30-minute lecture during the Awards
Session at the ASH Annual Meeting and will receive complimentary registration
and reimbursement for travel expenses and hotel accommodations.
Sponsors who wish to have their candidates nominated for an award must be current
ASH members and provide the following information:
||Complete name, address, phone, and fax numbers of the nominee
||A signed letter of nomination from the sponsor and at least one additional
supporting letter. The letters should clearly articulate the major contributions
of the nominee to the field of hypertension.
||A current curriculum vitae of candidate.
A candidate may be nominated by one or more different individuals within
the same year.
Previous winners of the ASH Distinguished Scientist Award and members of the
ASH Scientific Awards Committee are not eligble for nomination.
The Awards Committee will assess the candidates' overall scientific
contributions and their impact on the field of hypertension.
The ASH Distinguished Scientist Award recipient receives an award within
one of these five categories:
William Harvey Award
This award is named for scientist William Harvey (1578- 1657) who developed
the first accurate account of how the heart and circulatory system operated.
Richard Bright Award
This award is named for Richard Bright, (1789- 1858). Often referred to
as the Father of Nephrology, Dr. Bright is well known for his great contributions
to the study of the kidney.
Robert Tigerstedt Award
Robert Tigerstedt (1853- 1923) is recognized as an outstanding contributor
to both endocrinology and circulation. He is best known for his discovery
of the renin- angiotensin system.
Harriet Dustan Award
This award is named for Harriet P. Dustan, MD (1920 - 1999). Dr. Dustan
made many contributions to hypertension in her career of over 40 years.
These include her clinical and investigative achievements, especially
the concept of essential hypertension as a multifactoral disease of pressure
regulation. Dr. Dustan explored many of the pressor mechanisms and related
new knowledge to therapeutic concepts.
Irvine Page Award
This award is named for Irvine H. Page, MD (1901 - 1991). In Dr. Page's
long research career he made endless discoveries and contributions to
the treatment and espousal of hypertension. He may be best known for the
discovery and characterization of angiotensin, the identification of serotonin,
and the mosaic theory.
For more information, please contact:
Scientific Meetings and Professional Affairs
Associate Executive Director
American Society of Hypertension
244 Madison Avenue, Suite 136
New York, NY 10016
2015 ASH Distinguished Scientist Award
The American Society of Hypertension announced the recipient of the Robert
Tigerstedt Award, Sadayoshi Ito, MD, PhD.
The 2015 Award was presented during the ASH Thirtieth Annual Scientific
Meeting, during the Awards Session on Monday, May 18, 2015.
ASH Distinguished Scientist Award Recipient
Sadayoshi Ito, MD, PhD
Prof. Sadayoshi Ito is currently Executive Vice President (Director of Research Affair) of
Tohoku University in Sendai, Japan. Prof. Ito received his MD in 1979
and PhD in 1986 form the same university. Following clinical training,
he had undergone his fellowship at Henry Ford Hospital in USA from 1982
to 1984. Although he came back in Japan for a time, he returned to Henry
Ford Hospital as a Senior Staff Investigator in 1987. He came back to
Tohoku University as Associate Professor in 1995 and then was promoted
to Professor of Medicine in 1997. His research interests center on the
mechanism of renin release and glomerular hemodynamics. Prof. Ito developed
unique technologies for isolation and perfusion of a single glomerular
afferent or efferent arteriole, or for simultaneous perfusion of both
a single afferent arteriole and the attached macula densa. He demonstrated
directly that the macula densa indeed controls renin release and afferent
arteriolar tone. In addition, finding the similarity between renal and
cerebral circulation, Dr. Ito proposed and proved experimentally “strain
vessel theory” that can reasonably explain a close linkage between
microalbuminuria and cerebro-cardiovascular disease. He has also been
actively involved in many clinical studies (ROADMAP, ORIENT, INNOVATION,
etc.) Dr. Ito’s elegant research has been appreciated highly and
received many awards, including ASH Young Scholar Award (1993), Young
Investigator Award (Inter-American Society of Hypertension, 1993), Established
Investigator Award (American Heart Association, 1994), Academy Award (Japanese
Kidney Foundation, 2010), ISH-APSH the trustee’s lectureship award
(2012), Arthur C Corcoran Memorial Lecture Award (American Heart Association,
2014). He served as a Chief Editor of Nephron from 1999 to 2002, and fills
or has filled an important role in journals like Journal of American Society
of Nephrology and Hypertension Research.